GLP-1 Plus also slows digestion, so your body has more time to process food and reduce the urge to snack
High-dose or acute experiments in animals and cells did not show the toxic effects of EGT
Digestive symptoms such as persistent diarrhea, abdominal pain, rectal bleeding, unexplained weight loss, fever, severe bloating, food intolerance patterns, or nighttime bowel movements deserve medical attention
For many people struggling with blood sugar or weight issues, these medications have delivered impressive results
Discard sooner if: The solution becomes cloudy Contamination is suspected Lab SOPs specify a shorter timeframe Factors That Affect Stability Storage Conditions Direct sunlight, extreme heat, or freezing reduce shelf life
[1] GLP-1s remain covered for: BMI 40 (Class III/morbid obesity) Type 2 Diabetes (Mounjaro, not Zepbound) Major Adverse Cardiac Events history Employers who opt-in to add weight loss drug coverage California Medi-Cal Alert: GLP-1 Exclusion Effective January 1, 2026 If you have Kaiser through Medi-Cal, weight loss GLP-1 coverage is ending